Source: Eur Respir Monogr 2018; 82: 36-61
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Mario C. Raviglione. Evolution of the strategies for control and elimination of tuberculosis. Eur Respir Monogr 2018; 82: 36-61

Member's Comments

No comment yet.

Related content which might interest you: Evolution of TB control and elimination strategies Source: School Course 2012 - TB and M/XDR-TB: from clinical management to control and elimination Year: 2012 Key role of tuberculosis services funding mechanisms in tuberculosis control and elimination Source: Eur Respir J 2015; 45: 289-291 Year: 2015 The WHO strategy for TB control and elimination Source: Eur Respir Mon 2012; 58: 242-253 Year: 2012 Old ideas to innovate tuberculosis control: preventive treatment to achieve elimination Source: Eur Respir J 2013; 42: 785-801 Year: 2013 Cost-effectiveness of two latent tuberculosis infection screening strategies Source: International Congress 2018 – Current practices in and attitudes to screening for tuberculosis, and a discussion about genetic diversity Year: 2018 Effects of DOTS strategy on new confirmed tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 588s Year: 2006 Different genetics background of patients with latent tuberculosis infection versus active tuberculosis Source: International Congress 2017 – Asthma genetics and genomics in patients and populations Year: 2017 Conditional expanding post-exposure prophylaxis: a potential new tool for tuberculosis control Source: ERJ Open Res, 7 (1) 00723-2020; 10.1183/23120541.00723-2020 Year: 2021 A European framework for effective tuberculosis control Source: Eur Respir J 2002; 19: 590-592 Year: 2002 The impact of drug resistance on TB control and elimination Source: International Congress 2014 – New diagnostics and better treatments for multidrug and extensively drug-resistant tuberculosis (M/XDR-TB) Year: 2014 Strategies against multidrug-resistant tuberculosis Source: Eur Respir J 2002; 20: 66S-77S Year: 2002 Management of latent Mycobacterium tuberculosis infection: WHO guidelines for countries with a low tuberculosis burden Source: International Congress 2016 – ERS publications: a focus on recent guidelines and task forces Year: 2016 Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries Source: Eur Respir J 2015; 46: 1563-1576 Year: 2015 Monitoring during and after tuberculosis treatment Source: Eur Respir Monogr 2018; 82: 308-325 Year: 2018 Challenges and perspectives for improved management of HIV/Mycobacterium tuberculosis co-infection Source: Eur Respir J 2010; 36: 1242-1247 Year: 2010 The Improvement of tuberculosis infection control in prisons Source: Eur Respir J 2002; 20: Suppl. 38, 164s Year: 2002 Changes in the metabolism of Mycobacterium tuberculosis during the course of TB treatment Source: Virtual Congress 2021 – Immunological and molecular characterisation of tuberculosis disease and infection Year: 2021 Tuberculosis control strategy modelling Source: Annual Congress 2009 - Socio-economic impact of tuberculosis Year: 2009 The dynamics of tuberculosis incidence and diagnostics of latent tuberculosis tuberculosis infection in children of Ukraine. Source: International Congress 2018 – Groups who are susceptible to tuberculosis: children, pregnant women and elderly people Year: 2018